Jie Lu Selected Research

latency-associated nuclear antigen

7/2021	Correction for Lu et al., "Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Upregulates Survivin Expression in KSHV-Associated B-Lymphoma Cells and Contributes to Their Proliferation".
7/2014	Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1.
6/2014	Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
1/2012	Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation.
7/2011	The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
7/2009	Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Lu Research Topics

Disease

161	Neoplasms (Cancer) 12/2022 - 11/2002
29	Infections 12/2022 - 10/2007
26	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 09/2003
24	Inflammation (Inflammations) 10/2021 - 12/2012
19	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 06/2008
17	Stroke (Strokes) 01/2021 - 03/2007
15	Gout 11/2022 - 05/2015
14	Ischemic Stroke 01/2021 - 05/2008
13	Hypertension (High Blood Pressure) 01/2022 - 01/2004
12	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2011
11	Carcinogenesis 06/2021 - 04/2005
11	Tuberculosis (Tuberculoses) 01/2021 - 04/2013
10	Cognitive Dysfunction 01/2022 - 01/2018
10	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 07/2009
10	Infarction (Infarctions) 01/2020 - 07/2009
9	Glioma (Gliomas) 08/2022 - 08/2010
9	Fibrosis (Cirrhosis) 01/2022 - 11/2009
9	Parkinson Disease (Parkinson's Disease) 01/2022 - 08/2013
9	Wounds and Injuries (Trauma) 12/2021 - 12/2009
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 09/2008
9	Pancreatic Neoplasms (Pancreatic Cancer) 09/2017 - 06/2004
8	Carcinoma (Carcinomatosis) 04/2021 - 12/2007
8	Chronic Hepatitis B 10/2018 - 01/2015
8	Ischemia 01/2017 - 06/2010
8	Starvation 03/2006 - 01/2003
7	Type 2 Diabetes Mellitus (MODY) 01/2021 - 06/2007
7	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2008
7	Reperfusion Injury 10/2017 - 01/2013
7	Hepatitis 01/2016 - 01/2013
7	Melanoma (Melanoma, Malignant) 09/2015 - 05/2011
6	Temporal Lobe Epilepsy 12/2022 - 01/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 01/2017
6	Lung Neoplasms (Lung Cancer) 05/2022 - 03/2009
6	COVID-19 01/2022 - 11/2020
6	Atherosclerosis 10/2021 - 03/2009
6	Liver Neoplasms (Liver Cancer) 08/2021 - 01/2014
6	Lymphoma (Lymphomas) 07/2021 - 07/2009
6	Necrosis 01/2021 - 01/2013
6	AIDS-Related Complex (ARC) 01/2019 - 01/2012
6	Autoimmune Hepatitis 01/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

57	Proteins (Proteins, Gene)FDA Link 03/2022 - 03/2006
39	Pharmaceutical PreparationsIBA 12/2022 - 02/2006
31	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2014
19	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 09/2003
18	CytokinesIBA 01/2021 - 01/2012
14	Uric Acid (Urate)IBA 11/2022 - 05/2015
13	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 03/2006
13	Biological ProductsIBA 02/2022 - 03/2006
13	EnzymesIBA 01/2021 - 05/2009
11	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 06/2009
10	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 09/2003
10	AntibodiesIBA 02/2022 - 01/2013
10	Peptides (Polypeptides)IBA 07/2021 - 01/2010
10	AntigensIBA 01/2021 - 01/2013
10	Messenger RNA (mRNA)IBA 01/2021 - 10/2008
9	Silicon Dioxide (Silica)FDA LinkGeneric 06/2018 - 05/2007
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2022 - 04/2005
8	MicroRNAs (MicroRNA)IBA 05/2022 - 10/2009
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2004
8	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2016
8	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2004
8	Transcription Factors (Transcription Factor)IBA 01/2022 - 05/2007
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 03/2006
8	Small Interfering RNA (siRNA)IBA 07/2020 - 02/2007
8	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 02/2007
8	Folic Acid (Vitamin M)FDA LinkGeneric 02/2018 - 04/2011
8	Concanavalin AIBA 05/2016 - 01/2013
7	VaccinesIBA 12/2022 - 01/2016
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 09/2003
7	AutoantibodiesIBA 02/2022 - 11/2007
7	LipidsIBA 01/2022 - 01/2016
7	ORALIT (ORS)IBA 01/2022 - 06/2009
7	Therapeutic UsesIBA 01/2022 - 03/2006
7	Apolipoproteins E (ApoE)IBA 11/2021 - 10/2016
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2014
7	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2007
7	Angiotensin IIIBA 01/2019 - 03/2013
7	Neuroprotective AgentsIBA 06/2014 - 03/2007
6	LigandsIBA 12/2022 - 04/2005
6	Blood Glucose (Blood Sugar)IBA 01/2022 - 02/2007
6	CholesterolIBA 01/2022 - 03/2011
6	Long Noncoding RNAIBA 01/2022 - 09/2017
6	HDL CholesterolIBA 01/2022 - 01/2004
6	latency-associated nuclear antigenIBA 07/2021 - 07/2009
6	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 07/2008
6	palmidrolIBA 03/2021 - 08/2014
6	CateninsIBA 01/2021 - 01/2013
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2020 - 04/2014
6	InterferonsIBA 10/2018 - 03/2011
6	ChromatinIBA 01/2016 - 10/2009
6	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 07/2015 - 07/2009
6	Polysaccharides (Glycans)IBA 09/2014 - 05/2011

Therapy/Procedure

89	Therapeutics 11/2022 - 11/2002
28	Radiotherapy 01/2022 - 12/2007
17	Drug Therapy (Chemotherapy) 02/2022 - 07/2009
11	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2021 - 01/2011
8	Photothermal Therapy 12/2021 - 12/2016
8	Immunotherapy 01/2021 - 05/2011
8	Transplantation 11/2018 - 11/2007
7	Precision Medicine 01/2021 - 02/2015